Healthy Inc > Blog > generic Stugeron manufacturer
Posted on:

Who cannot take cinnarizine?

In the pharmaceutical industry, Cinnarizine is a versatile molecule acting as both an Antihistamine and a Calcium Channel Blocker. As a pharmacist and manufacturer, I view its safety profile with caution, as it has a direct impact on the central nervous system and specific contraindications that must be strictly observed to avoid severe neurological complications.

At your WHO-GMP facility in Mumbai, where you likely produce the 25 mg and 75 mg (Stugeron) strengths, identifying who cannot take this drug is vital for your technical dossiers and B2B marketplace compliance.

Strict Contraindications (Who MUST NOT take it)

  • Parkinson’s Disease (Absolute Contraindication): Cinnarizine is a dopamine antagonist. It can significantly worsen tremors and rigidity in Parkinson’s patients and has been known to cause Drug-Induced Parkinsonism in healthy elderly patients after long-term use.

  • Porphyria: It is considered unsafe for patients with this rare genetic blood disorder, as it may trigger acute attacks.

  • Severe Liver or Kidney Disease: Since the drug is metabolized by the liver and excreted by the kidneys, patients with severe impairment are at high risk for “accumulation toxicity.”

  • Hypersensitivity: Anyone with a known allergy to cinnarizine or other piperazine derivatives.

High-Risk Groups (Precautions Required)

  • The Elderly: Older adults are more susceptible to the “extrapyramidal” side effects (unusual muscle movements) and confusion.

  • Pregnant & Breastfeeding Women: Safety has not been established. It is generally not recommended unless the clinical benefit clearly outweighs the fetal risk. It is also not recommended during lactation.

  • Children under 5 Years: Cinnarizine is typically not licensed for use in children below the age of 5.

  • Glaucoma & Urinary Retention: Due to its mild anticholinergic effects, it can increase eye pressure (Primary Angle Closure Glaucoma) and worsen symptoms of an enlarged prostate.

  • Epilepsy: It may lower the seizure threshold in some patients.

Critical Interactions: The “Do Not Mix” List

Substance / Drug ClassTechnical Interaction Effect
AlcoholSevere Sedation: Alcohol significantly multiplies the drowsy effect of Cinnarizine.
CNS Depressants(e.g., Diazepam, Zolpidem) Increases the risk of respiratory depression and extreme lethargy.
Tricyclic Antidepressants(e.g., Amitriptyline) Enhances anticholinergic side effects like dry mouth and blurred vision.
BetahistineAntagonism: These two drugs work against each other; taking them together reduces the efficacy of both for vertigo.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Short-Term” USP: On your marketplace, emphasize that Cinnarizine is best used for acute episodes of vertigo (usually no more than 5 days) to avoid interfering with the brain’s natural “vestibular compensation” processes.

  • Stability for Export: Cinnarizine is light-sensitive. For export to Zone IVb tropical regions, utilizing Alu-Alu or Amber-colored PVDC blister packaging is essential to maintain a 36-month shelf life.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international tenders for Meniere’s disease and motion sickness.

Cinnarizine Tablets

Posted on:

When is the best time to take cinnarizine 25 mg?

In the pharmaceutical industry, Cinnarizine 25 mg is a piperazine derivative classified as an antihistamine and calcium channel blocker with specific selectivity for the vestibular system. As a pharmacist and manufacturer, I can tell you that the timing of this medication is the single most important factor in its efficacy, particularly for motion sickness.

At your WHO-GMP facility in Mumbai, you likely manufacture this in 25 mg (standard) and 75 mg (sustained-release) strengths.

Timing Strategy by Indication

IndicationBest Time to TakeClinical Reasoning
Motion Sickness2 Hours Before travelIt takes time to reach peak plasma concentration ($T_{max}$); taking it “as the boat leaves” is often too late.
Vertigo / Meniere’s3 Times DailyRequires steady-state blood levels to maintain vestibular suppression.
Peripheral VascularAfter MealsReduces potential gastrointestinal irritation during long-term maintenance therapy.

Mechanism: The Dual-Action Vestibular Suppressant

Cinnarizine is unique because it works on two different physiological fronts to prevent dizziness.

Labyrinthine Suppression: It inhibits the transmission of signals from the vestibular apparatus (inner ear) to the vomiting center in the brain.

Calcium Channel Blockade: It prevents the influx of calcium ions into the vestibular sensory cells. This “blunts” their response to the overstimulation caused by motion or inner ear disorders.

H1 Antagonism: Like other antihistamines, it blocks $H_1$ receptors, providing additional sedation that helps calm the autonomic nervous system during a dizzy spell.

The Pharmacist’s “Safety Check”

As you promote your firm on digital and social platforms, providing these technical warnings is essential for professional authority:

  • The Sedation Factor: As a first-generation antihistamine, Cinnarizine causes drowsiness. Advise B2B clients and end-users to avoid alcohol and refrain from driving.

  • The “Parkinsonian” Warning: In elderly patients, long-term use (months) should be monitored closely, as Cinnarizine can rarely cause extrapyramidal symptoms (tremors/rigidity) due to its weak dopamine-blocking effect.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai, Cinnarizine is a high-demand “Travel & ENT” molecule:

  • The “Chewable” Advantage: For motion sickness, rapid onset is a major selling point. On your marketplace, highlight if your 25 mg tablets are dispersible or chewable, as this allows for faster absorption in the stomach.

  • Stability for Export: Cinnarizine is relatively stable but sensitive to light and high humidity. At our facility, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is critical for export to Zone IVb tropical regions.

  • Niche Market Strategy: Position Cinnarizine as the “Golden Standard” for Meniere’s Disease in your digital ads. While newer drugs exist, its dual-action profile makes it a favorite for ENT specialists globally.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international markets like Southeast Asia and the Middle East.

Cinnarizine Tablets

Add to cart